Current Liabilities
Accounts Payable
Boston Scientific Accounts Payable increased by 14.2% to $1.14B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.2%, from $960.00M to $1.14B. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows an upward trend with a 17.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase can indicate better credit terms or increased production volume, while a decrease might suggest faster payments or reduced purchasing.
Detailed definition
The amount of money a company owes to its suppliers and vendors for goods and services purchased on credit. In a large-s...
Peer comparison
Companies with significant supply chain leverage often maintain high payables to maximize their own cash-on-hand.
Metric ID:
accounts_payableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $689.00M | $674.00M | $794.00M | $696.00M | $732.00M | $803.00M | $862.00M | $868.00M | $899.00M | $929.00M | $942.00M | $921.00M | $906.00M | $907.00M | $960.00M | $1.00B | $962.00M | $1.00B | $1.14B |
| QoQ Change | — | -2.2% | +17.8% | -12.3% | +5.2% | +9.7% | +7.3% | +0.7% | +3.6% | +3.3% | +1.4% | -2.2% | -1.6% | +0.1% | +5.8% | +4.6% | -4.2% | +4.2% | +14.2% |
| YoY Change | — | — | — | — | +6.2% | +19.1% | +8.6% | +24.7% | +22.8% | +15.7% | +9.3% | +6.1% | +0.8% | -2.4% | +1.9% | +9.0% | +6.2% | +10.5% | +19.2% |
Range$674.00M – $1.14B
CAGR+11.9%
Avg YoY Growth+10.5%
Median YoY Growth+9.0%
Current Streak2 quarters growth
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Boston Scientific's accounts payable?
- Boston Scientific (BSX) reported accounts payable of $1.14B in Q4 2025.
- How has Boston Scientific's accounts payable changed year-over-year?
- Boston Scientific's accounts payable increased by 19.2% year-over-year, from $960.00M to $1.14B.
- What is the long-term trend for Boston Scientific's accounts payable?
- Over 5 years (2020 to 2025), Boston Scientific's accounts payable has grown at a 17.4% compound annual growth rate (CAGR), from $513.00M to $1.14B.
- What does accounts payable mean?
- The total amount of money the company owes to its suppliers for items it has already received.